Paul De

Associate Director, Manufacturing at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Paul De's Colleagues at Alnylam Pharmaceuticals
Allan Duffy

Director, Medical Diagnosis, Value and Evidence Strategy Team

Contact Allan Duffy

Ben Wang

Senior Manager, Talent Planning & Development

Contact Ben Wang

Meghan Scott

Associate Director, Talent Acquisition Operations & Branding

Contact Meghan Scott

Kathryn Pleva

Principal Quality Control Analyst

Contact Kathryn Pleva

Janell Lauria

Manager, Medical Operations

Contact Janell Lauria

Andrew Girard

Quality Assurance Manager, GxP Training

Contact Andrew Girard

View All Paul De's Colleagues
Paul De's Contact Details
HQ
(617) 551-8200
Location
Cambridge, Massachusetts
Company
Alnylam Pharmaceuticals
Paul De's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Paul De
Paul De currently works for Alnylam Pharmaceuticals.
Paul De's role at Alnylam Pharmaceuticals is Associate Director, Manufacturing.
Paul De's email address is ***@alnylam.com. To view Paul De's full email address, please signup to ConnectPlex.
Paul De works in the SaaS industry.
Paul De's colleagues at Alnylam Pharmaceuticals are Allan Duffy, Jennifer Rollins Valentino, Ben Wang, Meghan Scott, Kathryn Pleva, Janell Lauria, Andrew Girard and others.
Paul De's phone number is (617) 551-8200
See more information about Paul De